Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Sphingosine 1-phosphate receptor 5 | ||
Ligand | BDBM196265 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | In Vitro Functional Activity (Agonism) on Human 51P5 Receptors | ||
EC50 | 50±n/a nM | ||
Citation | Smid, P; Iwema Bakker, WI; Coolen, HK; Sliedregt, LA; van Dongen, MJ; den Hartog, JA; Hobson, A Fused heterocyclic derivatives as S1P modulators US Patent US9670220 Publication Date 6/6/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
Sphingosine 1-phosphate receptor 5 | |||
Name: | Sphingosine 1-phosphate receptor 5 | ||
Synonyms: | EDG8 | Endothelial differentiation sphingolipid G-protein-coupled receptor 8 | S1P5 | S1PR5 | S1PR5_HUMAN | Sphingosine 1-phosphate receptor | Sphingosine 1-phosphate receptor Edg-8 | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 41796.42 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 398 | ||
Sequence: |
| ||
BDBM196265 | |||
n/a | |||
Name | BDBM196265 | ||
Synonyms: | US9670220, 278 | US9670220, 307 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H23F3N2O5 | ||
Mol. Mass. | 488.4557 | ||
SMILES | OC(=O)[C@H]1CC(C1)N1CCc2oc(nc2C1)-c1ccc(OCc2ccc(OC(F)(F)F)cc2)cc1 |r,wD:3.2,(11.82,-4.87,;10.31,-5.19,;9.84,-6.66,;9.28,-4.05,;7.75,-3.89,;7.28,-5.35,;8.81,-5.51,;5.94,-6.12,;5.94,-7.66,;4.61,-8.43,;3.28,-7.66,;1.81,-8.14,;.91,-6.89,;1.81,-5.65,;3.28,-6.12,;4.61,-5.35,;-.64,-6.89,;-1.41,-8.23,;-2.94,-8.23,;-3.72,-6.89,;-5.26,-6.89,;-6.03,-5.56,;-7.57,-5.56,;-8.34,-6.89,;-9.88,-6.89,;-10.65,-5.56,;-12.19,-5.56,;-12.96,-4.23,;-14.5,-4.23,;-12.19,-2.89,;-13.73,-5.56,;-9.88,-4.22,;-8.34,-4.23,;-2.94,-5.56,;-1.41,-5.56,)| | ||
Structure |